Xenotransplantation in the 21st century

Blood Purification

Volumn 20, Issue 1, 2002, Pages 45-54

  Perico, Norberto ^a   Benigni, Ariela ^a   Remuzzi, Giuseppe ^a,b  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Graft failure; Humoral and cellular immune responses; Immunologic reaction; Transplant donor shortage; Xenotransplantation

Indexed keywords

ALPHA GALACTOSIDASE; ANTIBODY; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD59 ANTIGEN; COMPLEMENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DECAY ACCELERATING FACTOR; DISACCHARIDE; EPITOPE; FUCOSYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA;

ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENT INHIBITION; DONOR; GRAFT FAILURE; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; INFECTION RISK; LEUKOCYTE ADHERENCE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; TRANSGENIC ANIMAL; VIRUS INFECTION; XENOTRANSPLANTATION; ANIMAL; ANTIBODY PRODUCTION; HISTOCOMPATIBILITY; IMMUNOLOGY; OPPORTUNISTIC INFECTION; REVIEW; XENOGRAFT;

ANIMAL; ANTIBODY FORMATION; GRAFT REJECTION; HUMAN; IMMUNITY, CELLULAR; OPPORTUNISTIC INFECTIONS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS; ANIMALS; HUMANS;

EID: 0036007322     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046985     Document Type: Article

References (74)

1. Xenotransplantation: A challenge for the future of transplant medicine
2. Greffe rénale
3. Nierentransplantationen
4. Prevention of transplant rejection. Current treatment guidelines and future developments
5. Renal heterotransplantation in man
6. Physiologic and immunologic hurdles to xenotransplantation
7. Natural antibodies and the immune response
8. Progress toward cardiac xenotransplantation
9. Transient perturbation of endothelial integrity induced by antibodies and complement
10. Transplantation of discordant xenografts: A review of progress
11. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts
12. Anti-pig IgM antibodies in human serum react predominantly with Gal(α1-3) Gal epitopes
13. Naturally occurring anti-galactosyl antibodies: Relationship to xenoreactive anti-galactosyl antibodies
14. Experimental renal heterotransplantation I In widely divergent species
15. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon
16. Pig-to-baboon renal xenografts
17. Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival
18. The role of natural anti-Gal1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants
19. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: Experience with 320 aphereses in baboons
20. The control of homologous lysis
21. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
22. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage
23. Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs
24. Three-month survival of hDAF transgenic pig hearts transplanted into primates
25. Splenectomy improves survival of hDAF transgenic pig kidneys in primates
26. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors
27. Orthotopic heart transplantation in a transgenic pig-to-primate model
28. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days
29. A human CD46 transgenic pig model system for the study of discordant xenotransplantation
30. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans
31. Evolutionary relationship between the natural anti-Gal-antibody and the Galα1-3Gal epitope in primates
32. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis
33. Reduction in the level of Gal(α1,3)Gal in transgenic mice and pigs by the expression of an α(1,2)fucosyltransferase
34. Combined transgenic expression of α-galactosidase and α-1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galα(1,3)Gal
35. Cloned piglets produced by nuclear transfer from adult somatic cells
36. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model
37. Activation of intragraft endothelial mononuclear cells during discordant xenograft rejection
38. Xenogenic human serum promotes leukocyte adhesion to porcine endothelium under flow conditions, possibly through the activation of the transcription factor NF-κB
39. Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases
40. Barriers to xenotransplantation
41. Xenogenic serum promotes thrombus formation on porcine endothelium under flow: Role of complement
42. Induction of procoagulant function in porcine endothelial cells by human NK cells
43. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species
44. Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers
45. Newborn discordant cardiac xenotransplantation in primates: A model of natural antibody depletion
46. A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens
47. Natural killer cells induce activated murine B cells to secrete Ig
48. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes
49. Target cell susceptibility to lysis by human natural killer cells is augmented by α-(1,3)-galactosyltransferase and reduced by α(1,2)-fucosyltransferase
50. Induction of B-cell tolerance by retroviral gene therapy
51. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal-α1,3Gal-mediated graft rejection
52. Tolerance induction for xenotransplantation
53. Detection of primary direct and indirect human anti-porcine T-cell responses using a porcine dendritic cell population
54. Phenotypic and functional maturation of dendritic cells modulated by heparan sulfate
55. New directions for organ transplantation
56. Discordant organ xenotransplantation in primates
57. Mixed chimerism as an approach for the induction of transplantation tolerance
58. Specific tolerance induction across a xenogenic barrier: Production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen
59. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption
60. Allogenic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
61. Advances in transplantation tolerance
62. Peripheral donor leukocytes prolong survival of rat renal allografts
63. Thymic microchimerism correlates with the outcome of tolerizing protocols for solid organ transplantation
64. Kidneys from hDAF transgenic pigs are physiologically compatible with primates
65. Life-supporting pig-to-baboon heart xenotransplantation
66. Microbiological characterization of porcine fetal islet-like cell clusters for intended xenografting
67. Biologic and immunologic properties of porcine type C viruses
68. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys
69. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue
70. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: Clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus
71. Transplantation of embryonic porcine mesencephalic tissue in patients with PD
72. Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs